Lori Murray

Lori Murray has extensive experience in investor relations and corporate communications. Lori is currently serving as the Senior Vice President of Investor Relations & Corporate Communications at Annexon Biosciences. Prior to this, Lori worked as a consultant at Captivate Communications & Investor Relations Consulting, and as the Chief Corporate Affairs Officer at Rubius Therapeutics. Before that, they ran their own consulting firm, Lori Murray Consulting, where they provided strategic counsel and support to executive teams for communications and investor relations activities for various clients. Lori also held positions at Amgen, Onyx Pharmaceuticals, WeissComm Partners (now Real Chemistry), Applied Biosystems (now ThermoFisher Scientific), and ReGen Biologics (now Stryker).

Lori Murray obtained their Bachelor of Arts degree in Rhetoric & Communications from the University of California, Davis, where they studied from 1993 to 1996. Lori later pursued their Master of Business Administration in Business Administration and Management, General at the University of San Francisco School of Management from 2003 to 2006.